Ketamine Nasal Spray: Compounded Racemic Ketamine for At-Home Use

Compounded ketamine nasal spray occupies a unique space in the ketamine therapy landscape. It offers the convenience of at-home nasal administration with higher bioavailability than oral routes, but it is distinct from -- and should not be confused with -- Spravato (esketamine), the FDA-approved nasal product.

Understanding the differences between compounded ketamine nasal spray and Spravato is essential for making informed treatment decisions. This guide explains what compounded nasal spray is, how it works, who it is appropriate for, and how it compares to other ketamine delivery methods.

What Is Compounded Ketamine Nasal Spray?

Compounded ketamine nasal spray is a custom-prepared intranasal formulation of racemic ketamine (containing both S- and R-enantiomers) made by a compounding pharmacy to a prescriber's specifications. It is delivered via a metered-dose nasal spray device, similar to over-the-counter allergy sprays.

Key Distinction from Spravato

This distinction is critically important:

| | Compounded Nasal Spray | Spravato | |---|---|---| | Active ingredient | Racemic ketamine | Esketamine (S-enantiomer only) | | FDA status | Not FDA-approved | FDA-approved (2019) | | Manufacturer | Compounding pharmacy | Janssen Pharmaceuticals | | Administration | At-home (self-administered) | In-facility (REMS supervised) | | Insurance | Not covered | Often covered | | Monitoring | Provider-recommended sitter | 2+ hours mandatory | | Regulation | State pharmacy boards | FDA REMS program |

How It Works

When sprayed into the nasal passages, ketamine is absorbed through the nasal mucosa -- the richly vascularized tissue lining the nose. This route provides:

• ~25-50% bioavailability: Higher than sublingual (~30%) but lower than IV (100%) or IM (~93%)
• Rapid absorption: Onset within 10-20 minutes
• Partial bypass of first-pass metabolism: More drug reaches the brain in active form compared to oral ingestion
• Direct nose-to-brain pathway: Some research suggests intranasal drugs may access the brain through olfactory and trigeminal nerve pathways, though the clinical significance of this for ketamine is still being studied

How Ketamine Nasal Spray Is Administered

Preparation

1. Clear nasal passages: Gently blow your nose before use. If you use nasal corticosteroids, apply them at least 1 hour before ketamine spray
2. Environment: Prepare a quiet, comfortable space. Have tissues nearby
3. Fasting: Avoid eating for 2 hours before (reduces nausea from post-nasal drip)
4. Sitter: Have someone present, especially for initial uses

Administration Technique

1. Prime the device: If it is a new bottle or has not been used in several days, prime by spraying 1-2 pumps into the air
2. Position: Sit upright or tilt head slightly forward (not backward)
3. Insertion: Place the spray tip just inside the nostril (about 1 cm)
4. Aim: Direct the spray slightly outward, toward the ear on that side (away from the septum)
5. Spray: Press the pump firmly while gently inhaling through the nose
6. Wait: Allow 30-60 seconds between sprays in each nostril
7. Alternate: If multiple sprays are prescribed, alternate between nostrils
8. After spraying: Do not blow your nose for at least 15-20 minutes
9. Rest: Lie back and allow the medication to take effect

After Administration

• Onset: 10-20 minutes for initial effects
• Peak: 20-40 minutes
• Duration: 60-90 minutes total experience
• Recovery: Rest for an additional 30-60 minutes
• Do not drive: Wait at least 6-8 hours

Dosing and Protocols

Typical Dosing

• Concentration: Usually compounded at 100 mg/mL or 200 mg/mL
• Dose per spray: 10-20 mg per actuation (depending on concentration and device)
• Typical session dose: 30-80 mg total (distributed across multiple sprays)
• Frequency: 1-3 times per week for maintenance

Common Schedules

| Use Case | Frequency | Duration | |----------|-----------|----------| | Maintenance after IV series | 2-3x/week initially, tapering | Ongoing | | Breakthrough symptom relief | As needed (provider-approved) | As needed | | Standalone maintenance | 2-3x/week | Ongoing | | Chronic pain maintenance | 1-3x/week | Ongoing |

Factors Affecting Absorption

Several factors influence how much ketamine is actually absorbed:

• Nasal congestion: Allergies, colds, or chronic sinusitis significantly reduce absorption
• Technique: Proper aim and gentle inhalation improve delivery
• Post-spray behavior: Blowing the nose or sneezing reduces absorption
• Mucosal health: Chronic nasal spray use (especially decongestants) can damage mucosa
• Formulation: The compounding pharmacy's formulation affects dissolution and absorption

Conditions Treated

Compounded ketamine nasal spray is prescribed for:

• Treatment-Resistant Depression: Maintenance therapy
• Anxiety Disorders: Ongoing management
• PTSD: Symptom maintenance and breakthrough episodes
• Chronic Pain: Pain management support
• Breakthrough symptom management: Some providers prescribe PRN (as-needed) doses for acute symptom flares

Research Evidence

Intranasal Ketamine Studies

Lapidus et al. (2014): A randomized controlled trial of intranasal ketamine (50 mg) for major depressive disorder found significant improvement in depression scores compared to saline placebo at 24 hours. This was among the first controlled studies demonstrating the viability of the intranasal route for psychiatric applications.

Andrade (2015): A review of intranasal ketamine for depression concluded that the route is "promising" with potential advantages in accessibility and ease of administration, while noting the need for larger controlled trials.

Pharmacokinetic Data

Yanagihara et al. (2003) and Clements et al. (2004): Foundational pharmacokinetic studies established the bioavailability range of 25-50% for intranasal ketamine, with significant variability based on formulation, volume, and individual nasal anatomy.

Huge et al. (2010): A pharmacokinetic study comparing intranasal to IV ketamine confirmed that nasal administration produces clinically relevant plasma concentrations with a faster onset than oral routes, supporting its use as a rapid-acting at-home option.

Emergency Department Research

Intranasal ketamine has been studied more extensively in emergency settings for acute pain:

Shimonovich et al. (2016): A study of intranasal ketamine in the emergency department found it effective for acute pain management, demonstrating the viability of the route for clinical applications.

The emergency department literature, while focused on pain rather than depression, has been important in establishing the safety and pharmacokinetic profile of intranasal ketamine delivery.

What to Expect During a Session

The Nasal Spray Experience

• Spray sensation: A brief burning or stinging in the nasal passages (usually mild)
• Post-nasal drip: Some bitter taste as medication drips down the back of the throat
• Onset: Gradual onset over 10-20 minutes
• Dissociation: Mild to moderate, typically less intense than IV
• Duration: Active experience lasts 60-90 minutes
• Nasal effects: Temporary nasal congestion or runny nose after the session

Common Side Effects

• Nasal irritation: Burning, stinging, or dryness in the nasal passages
• Bitter taste: From post-nasal drip
• Mild dissociation: Typical ketamine experience, milder than IV
• Dizziness: Usually mild and transient
• Nausea: Less common than with sublingual routes (less swallowed medication)
• Drowsiness: Plan to rest for the evening
• Runny nose: Temporary increase in nasal secretions

Pros and Cons

Advantages

• At-home convenience: Self-administered without clinic visits
• Higher bioavailability than sublingual: Potentially 25-50% vs. ~30% for oral routes
• Lower nausea risk: Less medication reaches the stomach compared to sublingual
• No bitter taste during administration: Unlike troches or sublingual liquid
• Rapid onset: Faster than oral routes
• Affordable per-dose cost: $20-$60 per session once the bottle is purchased
• Familiar format: Similar to using any nasal spray

Limitations

• Not FDA-approved: Compounded, off-label formulation
• Affected by nasal congestion: Allergies, colds, or sinus issues reduce effectiveness
• Variable bioavailability: 25-50% is a wide range depending on factors often outside patient control
• Nasal irritation: Can be uncomfortable, especially with frequent use
• Potential for mucosal damage: Long-term frequent nasal spray use may irritate nasal passages
• Not covered by insurance: Out-of-pocket cost
• Regulatory uncertainty: Compounded medications face an evolving regulatory landscape
• Confusion with Spravato: Patients and even some providers may confuse the two products

Cost and Insurance

Typical Pricing

| Item | Cost Range | |------|-----------| | Provider consultation | $100-$250 | | Nasal spray bottle (5-10 doses) | $100-$200 | | Per-dose cost | $20-$60 | | Monthly cost (2x/week) | $160-$480 | | Annual maintenance | $1,920-$5,760 |

Compared to Spravato

For patients without insurance coverage for Spravato, compounded nasal spray can be significantly more affordable:

• Compounded spray: $160-$480/month out of pocket
• Spravato without insurance: $2,000-$4,000+/month
• Spravato with insurance: $200-$800/month in copays

However, if your insurance covers Spravato well, the copay may be comparable to or lower than compounded spray.

Finding a Provider

Choosing a Compounding Pharmacy

Quality matters significantly for compounded nasal spray:

• PCAB accreditation or USP 795/797 compliance
• Experience with ketamine nasal formulations specifically
• Appropriate packaging: Metered-dose devices rather than uncontrolled dropper bottles
• Stability testing: Reputable pharmacies test formulation stability over time
• Consistent potency: Ask about potency verification testing

Provider Qualifications

Look for providers who:

• Have experience prescribing compounded ketamine (not just Spravato)
• Offer clear protocols for at-home nasal spray use
• Provide monitoring through regular follow-up appointments
• Can articulate why nasal spray is appropriate for your specific case
• Work with reputable compounding pharmacies

Search our clinic directory to find providers who prescribe compounded ketamine nasal spray for at-home use.

Is Ketamine Nasal Spray Right for You?

Compounded ketamine nasal spray may be a good fit if you:

• Need an at-home maintenance option with higher bioavailability than sublingual
• Prefer nasal administration over oral (no bitter taste during use)
• Do not qualify for or cannot access Spravato
• Want a rapid-onset at-home option for breakthrough symptom management
• Have good nasal health without chronic congestion

Consider other options if you:

• Have chronic nasal congestion, allergies, or a deviated septum
• Qualify for insurance-covered Spravato (may be more cost-effective)
• Prefer the known bioavailability of IV or IM treatment
• Have concerns about compounding pharmacy quality or regulation
• Need the most potent form of ketamine therapy for initial treatment

Discuss your options with a qualified provider to determine whether compounded nasal spray is appropriate for your treatment plan. Find a ketamine clinic near you to get started.